MIT researchers develop a wireless implant that detects low blood sugar and releases glucagon, offering a potential safety ...

Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. To continue reading ...

developing hypoglycemia, or low blood sugar, is an ever-present threat. When glucose levels become extremely low, it creates a life-threatening situation for which the standard treatment of care is ...

Injectable solution was found to prevent low blood sugar or hypoglycemia by stabilizing glucose levels. The finding provides a hope for diabetics.

Tests in mice suggest glucagon micelle could be used as a responsive system to prevent the onset of insulin-induced deep hypoglycemia.

Researchers aim to improve commercial glucagon stability and prevent hypoglycemia by using micelles: nanoscale, soap-like bubbles that can be customized to assemble or disassemble in different ...

Encapsulated glucagon for insulin-induced hypoglycemia dissolves when sugar levels get seriously low (less than 60 milligrams per deciliter, mg/dL), releasing the hormone into the bloodstream and ...

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

Pediatric hypoglycemia refers to low blood sugar in children. Learn the first-line treatments for pediatric hypoglycemia here.

Talk with your child’s doctor if you have questions about their dosage. Long-term treatment Zegalogue is meant to be used as needed when severe hypoglycemia occurs.

Sometimes your blood sugar levels can get too low, even if you don't have diabetes. Learn more about the causes and effective treatment methods.

There’s some new guidance on treating hypoglycemia, or low blood sugar, in long-term care communities. It’s specifically geared for healthcare workers, though anyone who is a caregiver for ...